Market Cap 526.55B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) N/A
PE Ratio 20.58
Forward PE 18.62
Profit Margin 15.84%
Debt to Equity Ratio 0.50
Volume 8,492,100
Avg Vol 8,615,194
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 99%
Beta 0.34
Analysts Strong Sell
Price Target $213.83

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
twincam
twincam Jan. 16 at 4:16 AM
$IBRX pharma buyout interest often tracks patent cliffs—when a company’s top drug is nearing loss of exclusivity, it needs new assets to replace future revenue. For that reason, the most logical “watchlist” acquirers are large oncology/biopharma players facing meaningful cliffs and with the balance sheet to do deals—especially $MRK (Keytruda LOE expected around 2028), $BMY Myers (Opdivo ~2028 and broader LOE exposure), and $JNJ &J (Stelara U.S. LOE in 2025).
0 · Reply
Suite510
Suite510 Jan. 16 at 3:21 AM
$JNJ $KVUE $SPX Stick w Cramer lol 😂 California (December 2025): A jury awarded $40 million to two women for ovarian cancer linked to J&J's baby powder in a significant bellwether trial bye 👋 💵 💵💵🍿
0 · Reply
Arunas1
Arunas1 Jan. 15 at 11:15 PM
$JNJ 212.00
0 · Reply
Suite510
Suite510 Jan. 15 at 8:44 PM
$JNJ $KVUE CNBC’s Jim Cramer delivers his daily Mad Dash. Wrong again Cramer JNJ has lost all the talc ovarian bell weather trials Stupid just like the other pinheads in my feed 😂👋🍿 Cheers 🥂
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 8:03 PM
$JNJ $MRNA Green
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 8:03 PM
$JNJ Because there wasn’t a settlement. That means each case goes to court individually. That means time and money for the plaintiffs, who have very little of both. The corporate legal system is the slowest of all and thousands of lawsuits means thousands of days in court. Plaintiff lawyers can’t go years before they get one case in front of a court that may or may not win, and if the do win it goes to appeal so add on at least two more years before appeals courts take them up. That’s years of no money coming in for the plaintiff lawyers. That means the firm closes and the process starts all over again. JnJ has endless money to pay lawyers. Know the company and its pipeline. Know the legal system and what to expect. Do your own DD and forget all the BS the lame ass media puts out for clicks… or stay away and don’t make any money.
0 · Reply
Arunas1
Arunas1 Jan. 15 at 7:57 PM
$JNJ 205
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 7:53 PM
$JNJ $MRNA What does this even mean? Alert! You have no idea what you’re talking about! Find a new hobby, stocks aren’t your thing kid.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 7:50 PM
$JNJ $KVUE Everyday same BS from this idiot. Wrong again dumbass!!!
0 · Reply
Arunas1
Arunas1 Jan. 15 at 7:41 PM
$JNJ $MRNA 🍌🍌
0 · Reply
Latest News on JNJ
The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

Jan 11, 2026, 7:40 AM EST - 4 days ago

The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

AMGN CVX HD KO MRK NKE PG


Cramer's Mad Dash: Johnson & Johnson

Jan 9, 2026, 9:59 AM EST - 6 days ago

Cramer's Mad Dash: Johnson & Johnson


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 15 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


The Big 3: JNJ, SNDK, TWLO

Dec 30, 2025, 1:31 PM EST - 16 days ago

The Big 3: JNJ, SNDK, TWLO

TWLO SNDK


More Upside For JNJ Stock In 2026?

Dec 30, 2025, 5:05 AM EST - 16 days ago

More Upside For JNJ Stock In 2026?


Dogs of the Dow Had a Strong Year as Dividends Paid Off

Dec 29, 2025, 1:56 PM EST - 17 days ago

Dogs of the Dow Had a Strong Year as Dividends Paid Off

HD IBM NKE UNH


Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 18 days ago

Best Dividend Kings: December 2025

ABBV ABM ABT ADM ADP AWR BDX


Final Trade: JNJ, NVO, UBER, BMY

Dec 15, 2025, 6:22 PM EST - 4 weeks ago

Final Trade: JNJ, NVO, UBER, BMY

BMY NVO UBER


US FDA grants priority voucher to J&J's blood cancer treatment

Dec 15, 2025, 10:39 AM EST - 4 weeks ago

US FDA grants priority voucher to J&J's blood cancer treatment


Johnson & Johnson: Reliable Cash Flows, Moderate Expectations

Dec 11, 2025, 7:05 PM EST - 5 weeks ago

Johnson & Johnson: Reliable Cash Flows, Moderate Expectations


twincam
twincam Jan. 16 at 4:16 AM
$IBRX pharma buyout interest often tracks patent cliffs—when a company’s top drug is nearing loss of exclusivity, it needs new assets to replace future revenue. For that reason, the most logical “watchlist” acquirers are large oncology/biopharma players facing meaningful cliffs and with the balance sheet to do deals—especially $MRK (Keytruda LOE expected around 2028), $BMY Myers (Opdivo ~2028 and broader LOE exposure), and $JNJ &J (Stelara U.S. LOE in 2025).
0 · Reply
Suite510
Suite510 Jan. 16 at 3:21 AM
$JNJ $KVUE $SPX Stick w Cramer lol 😂 California (December 2025): A jury awarded $40 million to two women for ovarian cancer linked to J&J's baby powder in a significant bellwether trial bye 👋 💵 💵💵🍿
0 · Reply
Arunas1
Arunas1 Jan. 15 at 11:15 PM
$JNJ 212.00
0 · Reply
Suite510
Suite510 Jan. 15 at 8:44 PM
$JNJ $KVUE CNBC’s Jim Cramer delivers his daily Mad Dash. Wrong again Cramer JNJ has lost all the talc ovarian bell weather trials Stupid just like the other pinheads in my feed 😂👋🍿 Cheers 🥂
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 8:03 PM
$JNJ $MRNA Green
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 8:03 PM
$JNJ Because there wasn’t a settlement. That means each case goes to court individually. That means time and money for the plaintiffs, who have very little of both. The corporate legal system is the slowest of all and thousands of lawsuits means thousands of days in court. Plaintiff lawyers can’t go years before they get one case in front of a court that may or may not win, and if the do win it goes to appeal so add on at least two more years before appeals courts take them up. That’s years of no money coming in for the plaintiff lawyers. That means the firm closes and the process starts all over again. JnJ has endless money to pay lawyers. Know the company and its pipeline. Know the legal system and what to expect. Do your own DD and forget all the BS the lame ass media puts out for clicks… or stay away and don’t make any money.
0 · Reply
Arunas1
Arunas1 Jan. 15 at 7:57 PM
$JNJ 205
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 7:53 PM
$JNJ $MRNA What does this even mean? Alert! You have no idea what you’re talking about! Find a new hobby, stocks aren’t your thing kid.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 15 at 7:50 PM
$JNJ $KVUE Everyday same BS from this idiot. Wrong again dumbass!!!
0 · Reply
Arunas1
Arunas1 Jan. 15 at 7:41 PM
$JNJ $MRNA 🍌🍌
0 · Reply
DragonAlgo
DragonAlgo Jan. 15 at 5:57 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-01-16 | Strike: $217.50 | Type: CALL Option Plan (premium): Entry: $1.61 Stop: $1.16 TP1: $2.09 TP2: $2.74 TP3: $3.86 Rules-based execution profile. 🔗 https://dragonalgo.com
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Jan. 15 at 2:24 PM
$GFS $JNJ congrats bulls. Options paid
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Jan. 15 at 1:51 PM
Did you notice there were no analysts asking questions yesterday during the $LEGN presentation, excluding the JP Morgan host? Not 1 (excluding the host)? FYI I have not listened to the full presentation yet. I'm not going to be able to listen to the presentation until this weekend. I did speed read the transcript just now on Seeking Alpha. It appears Mr. Huang did not allude to the $JNJ combo data nor did the JP Morgan analyst ask about it. As near as I can tell, again via speed read so I may have missed it, was that LEGN expects another strong year, which makes sense given it will be some time until the new J&J combo is approved. Can any of you offer any insight? $DCZ @2malcontent @outlawinvestor1 @Georgeson @DiamondHandsBTW
1 · Reply
Quantumup
Quantumup Jan. 15 at 1:27 PM
H.C. Wainwright reiterated $ORIC Buy/$23 $PFE $JNJ $TAK OTSKY $CGEM Here's what H.C. Wainwright said: https://x.com/Quantumup1/status/2011791470215286837?s=20
0 · Reply
Arunas1
Arunas1 Jan. 15 at 12:38 PM
$JNJ & $MRNA down $DIA $QQQ $SPY trade alert ‼️
0 · Reply
Suite510
Suite510 Jan. 15 at 4:46 AM
$JNJ $KVUE At stake: the major plaintiff-side firm’s cut of potentially $22 billion in claims brought by vaginal cancer patients who accused the health-care giant of selling asbestos-tainted talc products. JNJ lol 😂 I said 30B, i’m pretty close 🍿
1 · Reply
TheStockTraderHub
TheStockTraderHub Jan. 15 at 3:32 AM
$JNJ beautiful breakout today, new all time highs target hig. Wen $225? 📈
0 · Reply
JohnTrack
JohnTrack Jan. 14 at 11:45 PM
$JNJ loose leash, eyes on tape!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 14 at 11:37 PM
Enter: $JNJ Calls Strike Price: $215 Expiry Date: FEB 06 2026 Buy in Price: $4.60 - $4.65 Sell Price: $8.10 Profit : +76% (Turn every $1 into $1.76) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Buy_SoFi
Buy_SoFi Jan. 14 at 10:04 PM
$TLTFF Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/166009-ferring-pharmaceuticals-and-theralase-r-technologies-announce-clinical-development-agreement-to-investigate-combination-therapy-in-bladder-cancer.html $CGON $IBRX $MRK $JNJ
0 · Reply
JohnTrack
JohnTrack Jan. 14 at 10:03 PM
$JNJ quick blurb hit the feed... https://www.rapidticker.com/news/jnj-tecvayli-monotherapy-demonstrates-superior-progression-a
0 · Reply
FRAGMENTS
FRAGMENTS Jan. 14 at 8:34 PM
0 · Reply